| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Nature's Sunshine Products, Inc.$21.27
+0.01 (+0.05%)
F 16Pipeline Score Tools & Services · Commercial
Market Cap
384.23 M
EPS
1.12
P/E Ratio
20.02 $
Value Trade
5.03 M
SEC Financials
Q1 2026Dilution Risk
Revenue
122.89 M
Operating CF
-1.85 M
Total Assets
261.46 M
Total Liabilities
94.54 M
Equity
166.92 M
D/E Ratio
12,345
-1.09 %
Week
-17.95 %
1 Month
-18.32 %
3 Month
10.35 %
6 Month
9.69 %
5 Year
5,706.24 %
All Time
Cash Data
Cash Position
87.58 M
Monthly Burn
615.00 K
Runway
140.5 mo
Burn Trend
SEC Filing
May 7, 2026
Overview
Volume
60.83 K
52 Week Range
12.97 - 28.14
% held by Insiders
5.68 %
% held by Institutions
87.62 %
Enterprise Value
319.08 M
Total Shares
17.59 M
Short %
4.33 %
Float Shares
14.44 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Nature's Sunshine Products, Inc.
64Total events
0Upcoming
8Tier-1 (high impact)
2011 – 2017Coverage
Event history 64
Oct 31, 2016
◆Management ChangeCorporate
Joseph W. Baty appointed Executive Vice President and Chief Financial Officer
2016
◆Other Regulator MilestoneEx-US Regulatory
Expected to obtain direct-selling license in China in 2016
2015
▲Other Regulator MilestoneEx-US Regulatory
China market entry progressing on schedule for launch in late 2015
Aug 10, 2015
Q3 2015
◆Product LaunchPost-Market
E-commerce channel rollout in China expected in second-half of 2015
Jun 2015
▼Equity OfferingCorporate
Repurchased $3.8 million of common stock in first half of fiscal 2015
Drug Pipeline Intelligence
F16
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 13%
Micro Cap (rank 794 of 911)
Percentile RankNature's Sunshine Products, Inc. has significant pipeline risk (16/100).
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in NATR
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
NATR Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-07-17 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-07-17 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-07-17 | 0.00 | 0 | - | - | - | - | - | - | ||||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
NATREARNINGS RELEASE Exhibit FOR IMMEDIATE RELEASE NATURE'S SUNSHINE PRODUCTS REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS Second quarter net sales of $81.3 million were down 9.0% year-over-year Net loss of $0.2 million att
NATURE'S SUNSHINE PRODUCTS REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS LEHI, Utah, August 8, 2017 - Nature's Sunshine Products, Inc. (NASDAQ: NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care pro
Read more →NATRFourth Quarter 2016 Financial Highlights
NATURE'S SUNSHINE PRODUCTS REPORTS FOURTH QUARTER 2016 FINANCIAL RESULTS LEHI, Utah, March 7, 2017 - Nature's Sunshine Products, Inc. (NASDAQ: NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care prod
Read more →NATRJBATY PRESS RELEASE Exhibit FOR IMMEDIATE RELEASE Nature's Sunshine Products announces new chief financial officer
Nature's Sunshine Products announces new chief financial officer LEHI, Utah, October 31, 2016 - Nature's Sunshine Products (NASDAQ: NATR) ("NSP"), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care product
Read more →NATREARNINGS RELEASE Exhibit FOR IMMEDIATE RELEASE NATURE'S SUNSHINE PRODUCTS REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS Net sales revenue of $89.4 million was up 10.0% year-over-year; up 11.5% year-over-year on a local c
NATURE'S SUNSHINE PRODUCTS REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS LEHI, Utah, August 8, 2016 - Nature's Sunshine Products, Inc. (NASDAQ: NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care pro
Read more →NATRcyber security threats and exposure to data loss; its reliance on its information technology infrastructure; the sufficiency of trademarks and other intellectual property rights; changes in tax laws, treaties or regulati
NATURE'S SUNSHINE PRODUCTS ANNOUNCES THE RETIREMENT OF STEVE BUNKER AS EXECUTIVE VICE PRESIDENT, CHIEF FINANCIAL OFFICER AND TREASURER LEHI, Utah, March 7, 2016 - Nature's Sunshine Products, Inc. (NASDAQ: NATR), a leading natural health and wellness company engaged in the manufa
Read more →NATRFourth Quarter 2015 Financial Highlights
NATURE'S SUNSHINE PRODUCTS REPORTS FOURTH QUARTER AND FULL YEAR 2015 FINANCIAL RESULTS LEHI, Utah, February 25, 2016 - Nature's Sunshine Products, Inc. (NASDAQ: NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS Net sales revenue of $79.6 million was down 14.8% year-over-year; down 8.8% year-over-year on a local currency basis Earnings
NATURE S SUNSHINE PRODUCTS REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS Net sales revenue of $79.6 million was down 14.8% year-over-year; down 8.8% year-over-year on a local currency basis Earnings from continuing operations of $0.08 per diluted share Repurchased $6.1 million
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS Net sales revenue of $81.2 million was down 12.5% year-over-year; down 7.7% year-over-year on a local currency basis Diluted
NATURE S SUNSHINE PRODUCTS REPORTS SECOND QUARTER 2015 FINANCIAL RESULTS Net sales revenue of $81.2 million was down 12.5% year-over-year; down 7.7% year-over-year on a local currency basis Diluted EPS of $0.12, or $0.19, when excluding charges associated with the restructuring
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS FIRST QUARTER 2015 FINANCIAL RESULTS Third consecutive quarter of net sales growth for NSP Americas and Synergy Europe China market entry progressing on schedule f
NATURE S SUNSHINE PRODUCTS REPORTS FIRST QUARTER 2015 FINANCIAL RESULTS Third consecutive quarter of net sales growth for NSP Americas and Synergy Europe China market entry progressing on schedule for launch in late 2015 Announced plan to streamline operations and refocus Comp
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS FOURTH QUARTER AND FULL YEAR 2014 FINANCIAL RESULTS NSP Russia, Central and Eastern Europe sales continue to be depressed Second consecutive quarter of net sales g
NATURE S SUNSHINE PRODUCTS REPORTS FOURTH QUARTER AND FULL YEAR 2014 FINANCIAL RESULTS NSP Russia, Central and Eastern Europe sales continue to be depressed Second consecutive quarter of net sales growth for NSP United States, NSP Canada and Synergy Europe China market entry i
Read more →NATRNATURE S
NATURE S SUNSHINE PRODUCTS ANNOUNCES LEHI, UTAH, February 6, 2015 Nature s Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company engaged in the manufacture and direct sale of premium-quality nutritional and personal care products, today announced t
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS THIRD QUARTER 2014 FINANCIAL RESULTS Fifth consecutive quarter of record sales at Synergy WorldWide, driven by South Korea, Japan and a return to growth in Europe
NATURE S SUNSHINE PRODUCTS REPORTS THIRD QUARTER 2014 FINANCIAL RESULTS Fifth consecutive quarter of record sales at Synergy WorldWide, driven by South Korea, Japan and a return to growth in Europe NSP United States and NSP Canada show net sales growth for the first time since
Read more →NATRNATURE S SUNSHINE ANNOUNCES CLOSING OF PRIVATE PLACEMENT AND JOINT VENTURE AGREEMENT WITH FOSUN PHARMA Closed $46.2 million private placement transaction to fund China market entry Fosun Pharma acqu
NATURE S SUNSHINE ANNOUNCES CLOSING OF PRIVATE PLACEMENT AND JOINT VENTURE AGREEMENT WITH FOSUN PHARMA Closed $46.2 million private placement transaction to fund China market entry Fosun Pharma acquired 15% stake in Nature s Sunshine Declared $1.50 per share special cash divid
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS SECOND QUARTER 2014 FINANCIAL RESULTS Fourth consecutive quarter of record sales at Synergy WorldWide, driven by South Korea and Japan Strategic alliance with Fosu
NATURE S SUNSHINE PRODUCTS REPORTS SECOND QUARTER 2014 Fourth consecutive quarter of record sales at Synergy WorldWide, driven by South Korea and Japan Strategic alliance with Fosun Pharma to enter China through both direct selling and retail distribution channels Continuing w
Read more →NATRNATURE S SUNSHINE ANNOUNCES STRATEGIC ALLIANCE WITH FOSUN PHARMA Nature s Sunshine enters China, the fastest growing direct selling market in the world, with local strategic partner Companies will f
NATURE S SUNSHINE ANNOUNCES STRATEGIC ALLIANCE WITH FOSUN PHARMA Nature s Sunshine enters China, the fastest growing direct selling market in the world, with local strategic partner Companies will form a joint venture to market and distribute Nature s Sunshine and Synergy prod
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS Third consecutive quarter of record-setting sales at Synergy Worldwide, driven by South Korea and Japan. Overall sales were fl
NATURE S SUNSHINE PRODUCTS REPORTS FIRST QUARTER 2014 FINANCIAL RESULTS Third consecutive quarter of record-setting sales at Synergy Worldwide, driven by South Korea and Japan. Overall sales were flat year-over-year, reflecting weakness in Ukraine. Operating income increased 3.
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS Fourth quarter net sales revenue growth of 5.7 percent year-over-year (6.8 percent in local currency) Significa
NATURE S SUNSHINE PRODUCTS REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS Fourth quarter net sales revenue growth of 5.7 percent year-over-year (6.8 percent in local currency) Significant investment spending, resulting in lower operating income Board of Directors
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS Third quarter net sales revenue growth of 1.3 percent (2.4 percent in local currency) Significant investment spending, resulti
NATURE S SUNSHINE PRODUCTS REPORTS THIRD QUARTER 2013 FINANCIAL RESULTS Third quarter net sales revenue growth of 1.3 percent (2.4 percent in local currency) Significant investment spending, resulting in lower operating income margin Board of Directors approved a $0.10 per sha
Read more →NATRNATURE S SUNSHINE PRODUCTS NAMES RICHARD STRULSON AS EXECUTIVE VICE PRESIDENT, GENERAL COUNSEL
NATURE S SUNSHINE PRODUCTS NAMES RICHARD STRULSON AS EXECUTIVE VICE PRESIDENT, GENERAL COUNSEL, AND CHIEF COMPLIANCE OFFICER LEHI, Utah, October 3, 2013 Nature s Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company engaged in the manufacture and d
Read more →NATRGREGORY L. PROBERT APPOINTED CHIEF EXECUTIVE OFFICER OF NATURE S
GREGORY L. PROBERT APPOINTED CHIEF EXECUTIVE OFFICER OF NATURE S SUNSHINE PRODUCTS LEHI, Utah, October 2, 2013 Nature s Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS SECOND QUARTER FINANCIAL RESULTS, AND DECLARES SPECIAL ONE-TIME CASH DIVIDEND, REGULAR QUARTERLY CASH DIVIDEND AND $10
NATURE S SUNSHINE PRODUCTS REPORTS SECOND QUARTER FINANCIAL RESULTS, AND DECLARES SPECIAL ONE-TIME CASH DIVIDEND, REGULAR QUARTERLY CASH DIVIDEND AND $10 MILLION SHARE REPURCHASE PROGRAM LEHI, Utah, August 8, 2013 Nature s Sunshine Products, Inc. (NASDAQ:NATR), a leading natural
Read more →NATRNATURE S SUNSHINE PRODUCTS REPORTS FOURTH QUARTER AND FISCAL YEAR FINANCIAL RESULTS INCREASES QUARTERLY CASH DIVIDEND TO $0.10 PER SHARE Michael D. Dean to resign as CEO Gregory L. Probert, Executiv
NATURE S SUNSHINE PRODUCTS REPORTS FOURTH QUARTER AND FISCAL YEAR FINANCIAL RESULTS INCREASES QUARTERLY CASH DIVIDEND TO $0.10 PER SHARE Michael D. Dean to resign as CEO Gregory L. Probert, Executive Chairman, to become interim CEO LEHI, Utah, March 6, 2013 Nature s Sunshine
Read more →NATRNATURE S SUNSHINE PRODUCTS NAMES GREGORY L. PROBERT EXECUTIVE CHAIRMAN OF THE BOARD OF DIRECTORS
NATURE S SUNSHINE PRODUCTS NAMES GREGORY L. PROBERT EXECUTIVE CHAIRMAN OF THE BOARD OF DIRECTORS; KRISTINE F. HUGHES TO BECOME VICE CHAIRMAN OF THE BOARD OF DIRECTORS LEHI, Utah, December 13, 2012 Nature s Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and welln
Read more →Competitive Position
How NATR ranks across every disease it competes inCompetitive Position is a premium feature
See how NATR ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial